Evidence map›Paper›PMID 42792724›Full record

ArticleBiomedicines2026

Assessment of Interleukin-15 (IL-15) Concentration in Children with Cystic Kidney Disease.

Anna Bogdał, Aleksandra Hop, Elżbieta Świętochowska, Artur Janek, Tomasz Morelewski, Andrzej Badeński, Katarzyna Otrębska, Maria Szczepańska

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna BogdałDepartment of Pediatrics, District Hospital in Zawiercie, Miodowa Street 14, 42-400 Zawiercie, Poland.
Aleksandra HopChair and Clinical Department of Pediatrics, Hospital No. 2 in Bytom, ul. Stefana Batorego 15, 41-902 Bytom, Poland.
Elżbieta ŚwiętochowskaDepartment of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
Artur JanekDepartment of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13/15, 41-800 Zabrze, Poland.ORCID 0009-0009-6925-8409
Tomasz MorelewskiDepartment of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13/15, 41-800 Zabrze, Poland.
Andrzej BadeńskiDepartment of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13/15, 41-800 Zabrze, Poland.ORCID 0000-0001-6947-005X
Katarzyna OtrębskaPraski Hospital of the Transfiguration of the Lord, al. Solidarności 67, 03-401 Warsaw, Poland.ORCID 0009-0002-5169-5992
Maria SzczepańskaDepartment of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3 Maja 13/15, 41-800 Zabrze, Poland.ORCID 0000-0002-6772-1983

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic kidney disease is characterized by progressive structural remodeling of renal parenchyma and altered cellular signaling. Inflammatory mediators may contribute to disease biology; however, data on interleukin-15 (IL-15) in pediatric cystic kidney disorders remain limited. The aim of this study was to assess serum and urinary IL-15 concentrations in children with cystic kidney disease and to evaluate their association with renal function.

Indexed as

cystic kidney diseaseinterleukin-15pediatric nephrology

Identifiers

PMID42792724
PMCPMC13604047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.